Antihypertensive Agents

"Antihypertensive Agents" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus, MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure, which enables searching at various levels of specificity.

MeSH information

Definition | Details | More General Concepts | Related Concepts | More Specific Concepts

Drugs used in the treatment of acute or chronic vascular HYPERTENSION regardless of pharmacological mechanism. Among the antihypertensive agents are DIURETICS; (especially DIURETICS, THIAZIDE); ADRENERGIC BETA-ANTAGONISTS; ADRENERGIC ALPHA-ANTAGONISTS; ANGIOTENSIN-CONVERTING ENZYME INHIBITORS; CALCIUM CHANNEL BLOCKERS; GANGLIONIC BLOCKERS; and VASODILATOR AGENTS.

Descriptor ID	D000959
MeSH Number(s)	D27.505.954.411.162
Concept/Terms	Antihypertensive Agents Antihypertensive Agents Agents, Antihypertensive Antihypertensives Anti-Hypertensives Anti Hypertensives Antihypertensive Drugs Drugs, Antihypertensive Anti-Hypertensive Agents Agents, Anti-Hypertensive Anti Hypertensive Agents Anti-Hypertensive Drugs Anti Hypertensive Drugs Drugs, Anti-Hypertensive

Below are MeSH descriptors whose meaning is more general than "Antihypertensive Agents".

Chemicals and Drugs [D]
Chemical Actions and Uses [D27]
Pharmacologic Actions [D27.505]
Therapeutic Uses [D27.505.954]
Cardiovascular Agents [D27.505.954.411]
Antihypertensive Agents [D27.505.954.411.162]

Below are MeSH descriptors whose meaning is related to "Antihypertensive Agents".

Below are MeSH descriptors whose meaning is more specific than "Antihypertensive Agents".

publications

Timeline | Most Recent

This graph shows the total number of publications written about "Antihypertensive Agents" by people in this website by year, and whether "Antihypertensive Agents" was a major or minor topic of these publications.

Bar chart showing 148 publications over 23 distinct years, with a maximum of 12 publications in 2011

To see the data from this visualization as text, click here.

Year	Major Topic	Minor Topic	Total
2001	1	0	1
2002	1	1	2
2003	4	2	6
2004	3	2	5
2005	7	3	10
2006	1	6	7
2007	4	1	5
2008	8	2	10
2009	3	5	8
2010	5	1	6
2011	7	5	12
2012	2	2	4
2013	1	3	4
2014	5	2	7
2015	3	3	6
2016	3	5	8
2017	6	5	11
2018	5	5	10
2019	1	5	6
2020	5	0	5
2021	6	1	7
2022	1	5	6
2023	0	2	2

Below are the most recent publications written about "Antihypertensive Agents" by people in Profiles.

Wong MK, Bowers ME, Ventimiglia J, Niknam RM, Moster MR, Pro MJ, Dale E, Kolomeyer NN, Lee D, Zheng CX. Short-Term Outcomes of Bimatoprost Sustained-Release Intracameral Implant in Glaucoma. J Glaucoma. 2023 09 01; 32(9):738-743.

View in: PubMed
Ahmed M, Nudy M, Bussa R, Naccarelli GV, Filippone EJ, Foy AJ. A Subgroup Meta-Analysis Comparing the Renal Denervation Sham-Controlled Randomized Trials Among Those With Resistant and Nonresistant Hypertension. Am J Cardiol. 2023 Mar 15; 191:119-124.

View in: PubMed
Groenland EH, Dasgupta I, Visseren FLJ, van der Elst KCM, Lorde N, Lawson AJ, Bots ML, Spiering W. Clinical characteristics do not reliably identify non-adherence in patients with uncontrolled hypertension. Blood Press. 2022 12; 31(1):178-186.

View in: PubMed
Szabo Yamashita T, Shariq OA, Foster TR, Lyden ML, Dy BM, Young WF, Bancos I, McKenzie TJ. Unilateral Adrenalectomy for Primary Aldosteronism Due to Bilateral Adrenal Disease Can Result in Resolution of Hypokalemia and Amelioration of Hypertension. World J Surg. 2023 Feb; 47(2):314-318.

View in: PubMed
Sahai SK, Balonov K, Bentov N, Bierle DMM, Browning LM, Cummings KC, Dougan BM, Maxwell M, Merli GJ, Oprea AD, Sweitzer B, Mauck KF, Urman RD. Preoperative Management of Cardiovascular Medications: A Society for Perioperative Assessment and Quality Improvement (SPAQI) Consensus Statement. Mayo Clin Proc. 2022 09; 97(9):1734-1751.

View in: PubMed
Wong JC, Shiuey EJ, Razeghinejad R, Shukla AG, Kolomeyer NN, Myers JS, Pro MJ, Lee D. The effectiveness and tolerability of fixed-dose combination netarsudil 0.02%/latanoprost 0.005% at a tertiary glaucoma center. Graefes Arch Clin Exp Ophthalmol. 2023 Jan; 261(1):193-200.

View in: PubMed
Filippone EJ, Foy AJ, Naccarelli GV. Controversies in Hypertension II: The Optimal Target Blood Pressure. Am J Med. 2022 10; 135(10):1168-1177.e3.

View in: PubMed
Bello NR, LaMattina KC, Minor JM, Utz VM, Dong K, Levin AV. The risk of uveitis due to prostaglandin analogs in pediatric glaucoma. J AAPOS. 2022 06; 26(3):126.e1-126.e5.

View in: PubMed
Dasgupta I, Zoccali C. Is the KDIGO Systolic Blood Pressure Target <120 mm?Hg for Chronic Kidney Disease Appropriate in Routine Clinical Practice? Hypertension. 2022 01; 79(1):4-11.

View in: PubMed
Lane D, Lawson A, Burns A, Azizi M, Burnier M, Jones DJL, Kably B, Khunti K, Kreutz R, Patel P, Persu A, Spiering W, Toennes SW, Tomaszewski M, Williams B, Gupta P, Dasgupta I. Nonadherence in Hypertension: How to Develop and Implement Chemical Adherence Testing. Hypertension. 2022 01; 79(1):12-23.

View in: PubMed

People

Explore

Similar Concepts

Top Journals

The Thomas Jefferson University web site, its contents and programs, is provided for informational and educational purposes only and is not intended as medical advice nor is it intended to create any physician-patient relationship. Please remember that this information should not substitute for a visit or a consultation with a health care provider. The views or opinions expressed in the resources provided do not necessarily reflect those of Thomas Jefferson University, Thomas Jefferson University Hospital, or the Jefferson Health System or staff.
Please read our Privacy Statement